Could a mushroom boost liver recovery after cancer treatment?

NCT ID NCT07178093

Recruiting now Symptom relief Sponsor: Taichung Tzu Chi Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tests whether a mushroom extract called Antrodia cinnamomea can help liver cancer patients recover liver function and improve quality of life after a procedure called transcatheter arterial chemoembolization (TACE). Sixty adults with liver cancer will take either the supplement or a placebo for 11 days around the procedure. Researchers will measure liver enzyme levels and quality of life over 28 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Antrodia cinnamomea (a mushroom extract)
What this could lead to: If it works, this could show that Antrodia cinnamomea helps liver cancer patients recover liver function faster and feel better after a standard procedure called TACE.
What could go wrong: This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. The supplement is not a treatment for cancer itself, and its benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEPATOCELLULAR CARCINOMA TRANSARTERIAL CHEMOEMBOLIZATION

Contacts and locations

Locations

Taichung Tzu-Chi Hospital
RECRUITING

Taichung, Taiwan, 406, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.